Cataliq Laboratories

Manufacturing of human and veterinary pharmaceutical products with a focus on quality control and contract services in India.

About Cataliq Laboratories

Cataliq Laboratories is a Healthcare company. Manufacturing of human and veterinary pharmaceutical products with a focus on quality control and contract services in India. Its Indian entity Cataliq Laboratories Private Limited reported revenue of ₹4.94 Cr. Cataliq Laboratories offers products and services including Human Pharmaceuticals and Veterinary Formulations. Its focus areas include Contract Manufacturing, Outsourced Production, Pharmaceutical Services and Pharmaceuticals.

Company details

Cataliq Laboratories was established in June 1986 as a partnership firm in Ahmedabad, India, and began production through loan licenses before setting up its own unit in 1990. Facilities for manufacturing β lactum and non β lactum products, including tablets, capsules, and oral liquids for human and veterinary use, are maintained with continuous upgrades in technology and machinery. Quality control is ensured through equipped laboratories and adherence to Good Manufacturing Practices, with approvals from the Food and Drug Control Administration. Documentation procedures for raw materials and production operations are followed rigorously, emphasizing innovation and statutory compliance to achieve high standards.

Key Metrics
  • Indian entity revenue
    ₹4.94 Cr

    FY 2024 · -12% YoY

  • Indian entity net profit
    ₹76.5 Lakh

    FY 2024 · 15% margin

  • Indian entity EBITDA
    ₹1.14 Cr

    FY 2024 · 23% margin

Products & Services of Cataliq Laboratories

Cataliq Laboratories offers a comprehensive portfolio of products and services, including Human Pharmaceuticals and Veterinary Formulations.

Human Pharmaceuticals
Healthcare Products

A variety of human products, such as tablets, capsules, and injectables, are produced for β lactum and non β lactum applications

Veterinary Formulations
Animal Health Products

Veterinary products, including feed supplements and medicines like powders and suspensions, are manufactured for animal care purposes

Board of directors of Cataliq Laboratories Private Limited (Cataliq Laboratories)

Cataliq Laboratories Private Limited is the primary company behind Cataliq Laboratories. The board of Cataliq Laboratories Private Limited currently have 4 directors; the longest-serving is Randhir Mukundray Patwari, appointed in 1993. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Randhir Mukundray Patwari
DIN 02090864
Director30 Mar 199333 yrs 7 moCataliq Laboratories Private Limited
Nayna Randhir Patwari
DIN 02090865
Director30 Mar 199333 yrs 7 moCataliq Laboratories Private Limited
Nilay Randhir Patwari
DIN 02741773
Director01 Jul 200917 yrs 4 moCataliq Laboratories Private Limited
Mansi Nilay Patwari
DIN 08277132
Director13 Nov 20187 yrs 11 moCataliq Laboratories Private Limited

Financials of Cataliq Laboratories

Figures of Cataliq Laboratories Private Limited, the primary company behind Cataliq Laboratories, for FY 2024. Revenue was ₹4.94 Cr (-12% year on year). Net profit was ₹76.5 Lakh (15% margin). EBITDA was ₹1.14 Cr (23% margin). Revenue has grown at a compounded annual rate of +1% over three years and -2% over five years.

  • ₹4.94 CrRevenue · FY 2024 · -12% YoY
  • ₹76.5 LakhNet profit · 15% margin
  • ₹1.14 CrEBITDA · 23% margin
  • ₹5 LakhPaid-up capital
  • +1%Revenue CAGR, 3 years
  • -2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Cataliq Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for Cataliq Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cataliq Laboratories

The primary company behind Cataliq Laboratories, Cataliq Laboratories Private Limited, reported revenue of ₹4.94 Cr for FY 2024, down 12% year on year.

Cataliq Laboratories was established in June 1986 as a partnership firm in Ahmedabad, India, and began production through loan licenses before setting up its own unit in 1990. Facilities for manufacturing β lactum and non β lactum products, including tablets, capsules, and oral liquids for human and veterinary use, are maintained with continuous upgrades in technology and machinery. Quality control is ensured through equipped laboratories and adherence to Good Manufacturing Practices, with approvals from the Food and Drug Control Administration. Documentation procedures for raw materials and production operations are followed rigorously, emphasizing innovation and statutory compliance to achieve high standards.

Cataliq Laboratories offers Human Pharmaceuticals and Veterinary Formulations.

Cataliq Laboratories operates through Cataliq Laboratories Private Limited.

The legal entities of Cataliq Laboratories currently have 4 directors, including Randhir Mukundray Patwari, Nayna Randhir Patwari, Nilay Randhir Patwari and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available